Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum

Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum

Abstract Background Dementia prevalence is predicted to triple to 152 million globally by 2050. Alzheimer’s disease (AD) constitutes 70% of cases. There is an urgent need to identify individuals with preclinical AD, a 10–20-year period of progressive brain pathology without noticeable cognitive symp...

Full description

Bibliographic Details
Main Authors: Jane Alty, Lynette R. Goldberg, Eddy Roccati, Katherine Lawler, Quan Bai, Guan Huang, Aidan D Bindoff, Renjie Li, Xinyi Wang, Rebecca J. St George, Kaylee Rudd, Larissa Bartlett, Jessica M. Collins, Mimieveshiofuo Aiyede, Nadeeshani Fernando, Anju Bhagwat, Julia Giffard, Katharine Salmon, Scott McDonald, Anna E. King, James C. Vickers
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Neurology
Subjects:
Alzheimer’s disease
Dementia
TapTalk
Finger-tapping
Diadochokinesis
Computer vision
Online Access:https://doi.org/10.1186/s12883-024-03609-z

Internet

https://doi.org/10.1186/s12883-024-03609-z

Similar Items